How Vaccine Clinical Trials Work?
How Vaccine Clinical Trials Work, co-authored by Veristat and our colleagues at RBDCOV, one of 11 projects selected by the European Commission to prevent, mitigate, and respond to the impact of coronavirus and its variants.
Vaccines have a long history of successfully protecting people and communities against infectious diseases. As vaccine technologies advance, researchers can develop better and safer vaccines, as demonstrated by HIPRA’s recently approved BIMERVAX®, a bivalent adjuvanted vaccine based on the Beta and Alpha variants of SARS-CoV-2.
HIPRA leads the RBDCOV consortium and relies on fellow consortium member, the European Veristat team, for critical clinical trial activities. Veristat is proud to work with HIPRA and the RBDCOV Project partners and their dynamic and experienced teams, as we work together to solve complex challenges.
downloadPlease fill out this form to access your resource.